Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
As a guest to ChinaBio® Today, you have access to summaries of over 2500 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
Genovate to Build $55 Million Insulin Project in Changzhou | September 25, 2015
GuaHao Raises $394 Million for WeDoctor Healthcare Portal | September 25, 2015
China Issues Rules for Approval of Stem Cell Clinical Trials | September 10, 2015
Hengrui Medicine Licenses Cancer Drug to Incyte in $795 Million Deal | September 2, 2015
iKang Receives $1.1 Billion Go-Private Offer | September 1, 2015
Shanghai Pharma to Form $470 Million China Healthcare VC Fund | August 28, 2015>> See all top stories...
ChinaBio® in the News